News und Analysen

A fairly uninspiring set of quarterly results pushed AngioDynamics (NASDAQ: ANGO) stock down in value on Wednesday. The medical device and technology company saw its share price dip by almost 3% on

Shares of medical device manufacturer AngioDynamics (NASDAQ: ANGO) jumped 5.3% through 12:05 p.m. ET on Monday ahead of its expected earnings release next month. This morning, investment bank H.C

As a growth investor, few signs are as encouraging to witness from one of your holdings as a rapidly growing customer base. This is because such an occurrence typically means that the revenue of a

If you consider yourself a dividend investor, asking yourself the following question may aid in your success: What separates the wheat from the chaff among dividend stocks? Such a question gets you

Shares of Patterson Companies (NASDAQ: PDCO) fell as much as 14.2% early Wednesday, then partially recovered to trade down 5.6% as of 11.50 a.m. EDT after the company announced slightly

Novo Nordisk's (NYSE: NVO) molecule semaglutide is the active ingredient in its smash-hit therapies for weight loss and diabetes, which you've probably heard of under the trade names Wegovy and

Shares of Natera (NASDAQ: NTRA) were soaring 18.7% higher at 11:04 a.m. ET on Friday. The big gain came after the DNA testing company announced its second-quarter results following the market close

Shares of Nevro (NYSE: NVRO) were down more than 19% as of 3:30 p.m. ET on Wednesday after the company announced second-quarter earnings. The healthcare stock is down more than 49% so far this year

Achieving success as a growth investor revolves around picking companies that are taking new and potentially winning approaches to solving existing problems. These businesses can take their place as

Employer-sponsored retirement plans like the 401(k) are the primary tool working people use to save for their golden years. People used to spend all or most of their working years with one company

MicroVision (NASDAQ: MVIS) closed the work week in style, with its stock price rising by over 17% on Friday. That was a far better performance than the S&P 500 index's 1.2% increase. Investors

Last year, inflation rose at its fastest pace in over 40 years. The annual inflation rate, as measured by the year-over-year change in the Consumer Price Index (CPI), peaked at 9.1% in July 2022 and

Trupanion's (NASDAQ: TRUP) stock price had plummeted 15.6% this week as of Friday morning at 9:45 a.m. ET, according to S&P Global Market Intelligence. Trupanion was trading at about $22 per share